24.06.2015 • News

Americans Blame Drugmakers for High Prices

© Nikolai Sorokin - Fotolia.com
© Nikolai Sorokin - Fotolia.com

Americans are far more likely to blame pharmaceutical companies for high prescription medication costs than their health insurers, a recent poll has found. Of the 1,200 adults interviewed by the Kaiser Family Foundation’s researchers for the June Kaiser Health Tracking Poll, around three-quarters said the cost of prescription drug costs was unreasonable, but only10% of those responding blamed the high prices on co-pays demanded by their insurance company.

A similar majority said drug profits were a major factor in prescription prices, and 87% approved of enabling the Medicare program to negotiate prices with producers.

At the same time, over 70% of the poll’s respondents said they thought insurers should always pay for an expensive drug recommended by a doctor when no lower-cost alternative exists.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.